Accepting applications until August 1

City of Hope Intensive Course in Genomic Cancer Risk Assessment

Accepting applications until August 1

Newsroom

Guy Jerusalem: How Can Biomarkers Guide Breast Cancer Treatment De-escalation?

Guy Jerusalem: How Can Biomarkers Guide Breast Cancer Treatment De-escalation?

Guy Jerusalem, Professor at University of Liege, shared on LinkedIn: “Are you working in the field of breast cancer? Are you interested in writing a manuscript on systemic therapy escalation … Read More

Sep 14, 2026

Cancer Awareness in September: Advancing Research Across Cancer Types – Conquer Cancer

Cancer Awareness in September: Advancing Research Across Cancer Types – Conquer Cancer

Conquer Cancer, the ASCO Foundation shared on LinkedIn: “September marks awareness months for many different types of cancer-from childhood and gynecologic cancers to leukemia, lymphoma, thyroid, and prostate cancers. While … Read More

Sep 14, 2026

Olivier Laureau: Why Patient Voices Matter in Therapeutic Innovation

Olivier Laureau: Why Patient Voices Matter in Therapeutic Innovation

Olivier Laureau, President at Servier Foundation and Servier Group, shared on LinkedIn: “One of the most meaningful moments of my last visit to Japan was meeting Laureline Gatellier, a representative of … Read More

Sep 14, 2026

Emanuela Palmerini: How LRRC15 Targeting Translates Profiling into New Therapies in Osteosarcoma

Emanuela Palmerini: How LRRC15 Targeting Translates Profiling into New Therapies in Osteosarcoma

Emanuela Palmerini, Professor of Clinical Medicine at the University of Miami Miller School of Medicine, Medical Oncologist at IRCCS Istituto Ortopedico Rizzoli, shared European Society for Medical Oncology (ESMO)’s post … Read More

Sep 14, 2026

Yüksel Ürün: Can Non-Tumor-Specific T Cells Destroy Cancer?

Yüksel Ürün: Can Non-Tumor-Specific T Cells Destroy Cancer?

Yüksel Ürün, Professor of Medical Oncology at Ankara University, shared on X: “Can non-tumor-specific T cells destroy cancer? A new study shows activating bystander T cells inside tumors can kill cancer … Read More

Sep 14, 2026

Marco Tagliamento: How Immunotherapy Reshaped Lung Cancer Care

Marco Tagliamento: How Immunotherapy Reshaped Lung Cancer Care

Marco Tagliamento, Medical Oncologist and Researcher at the University of Genoa, shared on X: “Glad to have contributed to the JTO online 20th anniversary series! Immunotherapy has reshaped the treatment … Read More

Sep 14, 2026

Fight Colorectal Cancer Welcomes 3 New Organizations to the Colorectal Cancer Care Initiative

Fight Colorectal Cancer Welcomes 3 New Organizations to the Colorectal Cancer Care Initiative

Fight Colorectal Cancer shared on LinkedIn: “We’re proud to welcome three new organizations to the Colorectal Cancer Care Initiative (CRCCI): the V Foundation, Colorectal Cancer Equity Foundation, and First Ascent … Read More

Sep 14, 2026

Jason Luke: Advancing Novel Self-Replicating RNA Technologies

Jason Luke: Advancing Novel Self-Replicating RNA Technologies

Jason Luke, Chief Medical Officer at Strand Therapeutics, shared by Fierce Biotech, on LinkedIn: “We appreciate the call out regarding our novel self-replicating RNA technologies at Strand Therapeutics!” Quoting Fierce … Read More

Sep 14, 2026

Yago Garitaonaindía: TAISHAN-302 Marks Another Milestone in Small-Cell Lung Cancer

Yago Garitaonaindía: TAISHAN-302 Marks Another Milestone in Small-Cell Lung Cancer

Yago Garitaonaindía, Translational Research Fellow at CCIT-DK – National Center for Cancer Immune Therapy of Denmark, shared on X: “Waking up with another milestone in SCLC coming from WCLC26. TAISHAN-302: … Read More

Sep 14, 2026

Lorenza Rimassa: Looking Ahead to the Future of GI Oncology

Lorenza Rimassa: Looking Ahead to the Future of GI Oncology

Lorenza Rimassa, Associate Professor of Medical Oncology at Humanitas University and Head of the Hepatopancreatobiliary Oncology Unit at Humanitas Cancer Center, shared on LinkedIn: “It was a great pleasure to … Read More

Sep 14, 2026